Switzerland: 1Q Health strengthens European CDMO offering with acquisition of Gelpell
European CDMO Group 1Q Health, part of Nord Holding’s portfolio, is continuing its growth across Europe with the acquisition of Swiss softgel expert Gelpell, a full-service manufacturer of...
Switzerland: Pinova Capital invests in Ideal-tek’s next stage of growth
Funds managed by Germany-based Pinova Capital, an independent private equity firm investing in industrial tech companies in the German-speaking region have acquired a stake...
Finland: Legrand Care strengthens in Nordics with Axel Health
Legrand Care, a specialised technology division within the Legrand Group - a global specialist in electrical and digital infrastructures for buildings, headquartered in France...
Italy: Nico Brezan appointed CEO at RanD
Nico Brezan has been appointed as the new CEO at RanD Spa, an Italian medical device company and a portfolio company of Switzerland-based investor...
Netherlands: argenx to acquire Forte Biosciences for US$2.2bn
Dutch/Belgian Euronext- and Nasdaq-listed argenx, a global immunology innovation company, is to acquire Nasdaq-listed Forte Biosciences, a clinical-stage biopharmaceutical company, for US$77 per share...
Switzerland: BC Partners to invest in InfoRLife in partnership with Italy’s ACS Dobfar
International investment firm, BC Partners, has agreed to acquire a co-control stake in Switzerland-headquartered InfoRLife from its founder and CEO Sergio Dusci and the...
Singapore: HST Medical acquired by Kowa Pharmaceutical Asia to scale health brands globally
HST Medical, a Singapore-based provider of health supplements and traditional remedies, has been acquired by Singapore-based Kowa Pharmaceutical Asia, a sub-subsidiary of Japan’s Kowa...
Italy: Goldman Sachs Alternatives to acquire Numantec in support of company’s growth
Goldman Sachs Alternatives has agreed to acquire a majority stake in Numantec an Italy-headquartered global developer, manufacturer, and distributor of infusion medical devices, from...
Sweden: Atlas Health Capital to invest in AGB-Pharma
UK-based healthcare investor, Atlas Health Capital, has agreed to acquire AGB-Pharma, an independent, Swedish, family-owned, pharmaceutical company that focuses on sleep health and specialises...
Longevity’s next phase: from consumer hype to healthcare economics – Insights from the Investors...
Longevity is becoming one of healthcare's broadest and most contested investment themes. The market stretches from supplements, skincare and medical aesthetics to genomics, diagnostics,...
Advertisement
